Phase II Trial of CCI-779 (Temsirolimus) in Patients With Locally Advanced or Metastatic Breast Cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2018
At a glance
- Drugs Temsirolimus (Primary)
- Indications Advanced breast cancer
- Focus Pharmacogenomic; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 17 Jun 2008 Status changed from suspended to in progress as reported by ClinicalTrials.gov.
- 21 Aug 2007 Status changed from rccruiting to suspended.